Short Interest in Bavarian Nordic A/S (OTCMKTS:BVNRY) Grows By 1,450.0%

Bavarian Nordic A/S (OTCMKTS:BVNRY) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 6,200 shares, a growth of 1,450.0% from the November 15th total of 400 shares. Based on an average daily trading volume, of 51,200 shares, the short-interest ratio is currently 0.1 days.

Bavarian Nordic A/S Stock Performance

Shares of Bavarian Nordic A/S stock traded down $0.16 during trading on Wednesday, hitting $9.05. 11,914 shares of the stock were exchanged, compared to its average volume of 32,858. The stock’s fifty day moving average is $9.84 and its 200 day moving average is $9.97. Bavarian Nordic A/S has a 12 month low of $6.86 and a 12 month high of $14.60. The stock has a market cap of $2.14 billion, a PE ratio of 13.11 and a beta of 1.65.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.